New injection aims to wake muscles after surgery
NCT ID NCT07195604
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This early-stage study tests a single dose of HRS-2162 injection in 64 healthy adults aged 18-45. The goal is to check if the drug is safe and how the body processes it, with the future aim of reversing muscle paralysis caused by anesthesia. Participants must be in good health and use birth control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REVERSAL OF NEUROMUSCULAR BLOCKADE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sichuan Academy of Medical Sciences &Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
Contact
Conditions
Explore the condition pages connected to this study.